From Laboratory to Classroom: Waton Co., Ltd. Partners with Top Taiwanese Universities to Build a Medical Research Talent Reservoir

Focusing on basic science and compliant R&D, Waton Co., Ltd. promotes the internationalization of Asian medical technology talent through deep industry-university integration.

Press Release Summary

Waton Co., Ltd. officially announced today the launch of its "Young Scientific Research Talent Cultivation Program" in Taiwan and has reached strategic industry-university cooperation intentions with several renowned Taiwanese institutions of higher learning. This collaboration aims to deeply integrate the basic scientific research resources of the Japanese headquarters with the academic research capabilities of Taiwanese universities to jointly tackle frontier topics such as biological sample processing, standardized processes for stem cell extraction, and AI health data models. Waton Co., Ltd. emphasizes that all cooperative projects strictly follow a compliant R&D framework labeled "Research Use Only," with a focus on basic science exploration rather than clinical application. By establishing joint laboratories and providing project research scholarships and international academic exchange opportunities, Waton Co., Ltd. is committed to building a rigorous, professional academic platform for Taiwanese scientific research talent that connects with the international stage. This move not only demonstrates Waton Co., Ltd. 's sincerity in rooting itself in Taiwan and giving back to the academic community but also lays a solid talent foundation for the long-term technical reserves of the Asian big health industry.


23/12/2025

In an era where biotechnology and information technology are accelerating their convergence, the depth of basic research determines the breadth of industrial development. Waton Co., Ltd. announced today that it has established strategic industry-university-research alliances with multiple top universities in Taiwan to jointly launch basic research projects targeting the future of medical technology. By introducing the company's profound Back-end R&D experience into academic halls, Waton Co., Ltd. is not only committed to the collaborative cultivation of talent but is also driving breakthroughs in basic biotech theories within a framework of compliant R&D and technical standardization. Waton Co., Ltd. believes that continuous investment in young scientific research talent will inject lasting innovative momentum into the medical research ecosystem of Asia and the world.

In this industry-university cooperation, Waton Co., Ltd. has explicitly placed its focus on the field of "Fundamental Research." Distinct from the development of commercial products, the cooperation themes between Waton Co., Ltd. and Taiwanese universities are primarily concentrated on stability studies of biological samples, quality control standards in the stem cell extraction process, and underlying algorithms for data mining.

Waton Co., Ltd. believes that all technological innovations stem from a reverence for basic science. Therefore, the cooperation projects are conducted in rigorous laboratory environments, ensuring that every research process complies with internationally recognized academic norms. Through this return to the essence of scientific research cooperation, Waton Co., Ltd. hopes to contribute more technical white papers and academic papers of reference value to the industry, continuously exploring the boundaries of human health in the field of pure science without involving any form of clinical application or efficacy verification.

To ensure the professionalism and compliance of scientific research activities, Waton Co., Ltd. plans to establish "Joint Laboratories for Smart Health Basic Research" in collaboration with partner universities. The laboratories will introduce advanced equipment and R&D management systems from Waton Co., Ltd. ’s Japanese headquarters, with all operating procedures strictly complying with local regulatory requirements.

Within the operational logic of the laboratories, "Compliant R&D" is placed first. Every study targeting stem cells or AI algorithms is clearly labeled "Research Use Only." By opening its back-end experimental data and quality control systems to the academic community, Waton Co., Ltd. assists university researchers in verifying scientific hypotheses within a safe and compliant framework. This transparent and standardized R&D model not only improves scientific research efficiency but also sets a benchmark for compliant collaboration between industry and academia.

Waton Co., Ltd. knows that talent is the most core driver of scientific research. Therefore, this cooperation specifically establishes the "Waton Young Scholar Scholarship" and the "International Scientific Research Practice Program."

Through this program, outstanding students majoring in biomedicine, computer science, and other related fields at Taiwanese universities will have the opportunity to participate directly in Waton Co., Ltd. ’s back-end R&D projects under the guidance of mentors. Top performers may even obtain opportunities for deep academic exchange at the Japanese headquarters' laboratories. Waton Co., Ltd. provides not only financial support but also a real and demanding scientific research environment, allowing students to encounter the world's most cutting-edge scientific research quality control standards during their studies. This achieves a seamless connection from theoretical learning to scientific practice, reserving cross-disciplinary composite talent with an international perspective for Asia.

Through continuous and deep industry-university-research integration, Waton Co., Ltd. is constructing a virtuous scientific research ecological closed loop. Universities obtain valuable R&D resources and industrial perspectives through cooperation, while Waton Co., Ltd. continuously optimizes its underlying technical logic through original innovation from the academic community.

This cooperation model is not a short-term behavior but an important part of "Technical Sovereignty" within Waton Co., Ltd. 's global strategy. By deeply cultivating talent cultivation and basic research in the fertile ground of Taiwan's scientific research community, Waton Co., Ltd. aims to establish a decentralized global R&D network. In the future, the scientific research results and talent emerging from these joint laboratories will become the most solid underlying cornerstones supporting Waton Co., Ltd. ’s global smart health service system, steadily promoting the progress of human health through the power of science.


About Waton Co., Ltd.

Waton Co., Ltd. is a high-end medical technology enterprise headquartered in Tokyo, Japan. Its business covers stem cell extraction technology standard research, AI smart health management, high-end medical device R&D assistance, and early R&D support for innovative drugs. Adhering to the mission of "Technology Guards Life, Love Warms Society," the company is committed to building a world-leading medical resource integration and health service platform through its Japan-Taiwan dual-core strategy. Through back-end R&D alliances and digital tools, Waton Co., Ltd. provides compliant, rigorous, and forward-looking health solutions for global users and partners.

Whether it’s restoring health, reversing the effects of time, or enhancing the quality of life,

We are here to help your cells reboot the future.